Skip to main content

J&J Subsidiary Slammed With $80M Verdict

J&J Subsidiary Slammed With $80M Verdict

J&J Subsidiary Slammed With $80M Verdict

Introduction

On Friday, May 17, a Philadelphia jury awarded $80 million in a pelvic mesh verdict to plaintiffs over alleged damages against Johnson & Johnson subsidiary Ethicon.

According to the plaintiffs’ attorney, a woman had the mesh implanted in 2008 to treat her organ prolapse, but the product gradually had worn away leaving her with significant infections, inflammation, and pain that required several revision surgeries. The Philadelphia Court of Common Pleas Judge Daniel Anders granted $80.025 million to the woman and her husband of Media, Pennsylvania, which also included $50 million in punitive damages.

Ethicon pelvic mesh lawsuits are consolidated as a part of multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) before U.S. District Judge Joseph R. Goodwin in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.